01/2025 – To the start of the new year ADT Biotech’s LyteStar™ Enterovirus HFMD Typing Kit has achieved regulatory approval by the Malaysian Medical Device Authority (MDA). The LyteStar™ Enterovirus HFMD Typing Kit is intended for the specific detection and subtyping of Enterovirus RNA in human throat, vesicles, lesions or rectal swabs in VTM, and blood and cerebrospinal… Continue reading LyteStar™ Enterovirus HFMD Typing Kit receives market authorization in Malaysia
ADT Biotech’s LyteStar™ Influenza Typing RT-PCR Kit is now available in Thailand after achieving regulatory approval by the Thailand Food and Drug Administration (Thai FDA).
ADT Biotech’s recently introduced product, the LyteStar™ Arbovirus ZCD Kit has obtained market authorization by the Malaysian Medical Device Authority (MDA). The LyteStar™ Arbovirus ZCD Kit has been developed for the specific detection and differentiation of the three mosquito-borne viruses Dengue, Chikungunya and Zika in a single reaction format. The assay targets a conserved 3’UTR region specific for… Continue reading LyteStar™ Arbovirus ZCD Kit achieves MDA approval in Malaysia
ADT Biotech’s latest product, the LyteStar™ COVID / Flu / RSV Differentiation Kit has achieved regulatory approval by the Malaysian Medical Device Authority (MDA). The LyteStar™ COVID / Flu / RSV Differentiation RT-PCR Kit is a four-target assay intended for the specific detection of SARS-CoV-2, Influenza A, Influenza B and Respiratory Syncytial Virus (RSV) RNA in human respiratory… Continue reading LyteStar™ COVID / Flu / RSV Differentiation Kit obtains market authorization in Malaysia